title: Fetal hemolytic anemia associated with maternal sulfasalazine therapy during pregnancy.
authors.affiliation: Institute for the Health of Women and Children, Sahlgrenska University Hospital/East, Goteborg, Sweden. hans.i.bokstrom@vgregion.se
authors.forename: Hans
authors.initials: H
authors.lastname: Bokström
authors.forename: Rose-Marie
authors.initials: RM
authors.lastname: Holst
authors.forename: Ola
authors.initials: O
authors.lastname: Hafström
authors.forename: Birgitta
authors.initials: B
authors.lastname: Swolin
authors.forename: Mari Louise
authors.initials: ML
authors.lastname: Johansson
authors.forename: Gertrud
authors.initials: G
authors.lastname: Brunlöf
authors.forename: Thomas
authors.initials: T
authors.lastname: Hedner
mesh_terms: D000328:Adult; D000743:Anemia, Hemolytic / Q000139:chemically induced* / Q000628:therapy; D001805:Blood Transfusion, Intrauterine; D003093:Colitis, Ulcerative / Q000188:drug therapy; D005260:Female; D005315:Fetal Diseases / Q000139:chemically induced* / Q000628:therapy; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000009:adverse effects*; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D011247:Pregnancy; D012460:Sulfasalazine / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D005765:Gastrointestinal Agents; D006454:Hemoglobins; D012460:Sulfasalazine